Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. annual/quarterly long term debt history from 2023 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Rhythm Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 100.9M, a 6.82% decrease year-over-year.
- Rhythm Pharmaceuticals Inc. long term debt for 2025 were 100.9M, a 6.82% decrease from 2024.
- Rhythm Pharmaceuticals Inc. long term debt for 2024 were 108.3M, a 2.00% increase from 2023.
- Rhythm Pharmaceuticals Inc. long term debt for 2023 were 106.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Rhythm Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $101 |
| 2024 | $108 |
| 2023 | $106 |
| Rhythm Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $101 |
| 2024-12-31 | $108 |
| 2023-12-31 | $106 |
Rhythm Pharmaceuticals Inc. Long Term Debt — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RYTM's long term debt history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.